Genelux GNLX
NASDAQ GNLX
$2.07 -0.43 (-17.20%)
At close: Oct 21, 2026 · 4:00 PM EDT

Genelux (GNLX) EPS (Basic) (2022 - 2026)

Updated

Genelux (GNLX) reported EPS (Basic) of -$0.20 for Q1 2026, compared with -$0.21 a year earlier.

Analysis

Genelux (GNLX) EPS (Basic) (2022 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Genelux's EPS (Basic) came in at -$0.76; for FY2025, it came in at -$0.86.

  • By year, EPS (Basic) came in at -$0.95 in FY2024, -$1.16 in FY2023 and -$0.57 in FY2022.
  • Five-year quarterly EPS (Basic) spans a low of -$0.53 in Q1 2023 and a high of $0.54 in Q3 2022.
  • Per Business Quant data, the three quarters before Q1 2026 came in at -$0.25 (Q4 2025), -$0.21 (Q3 2025) and -$0.20 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 2.30
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.04
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -0.54
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.68
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.62
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -8.44
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -0.04
10 Genelux 91.17 Mn 29.45 Mn - -0.20
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.20
Dec 31, 2025 -0.25
Sep 30, 2025 -0.21
Jun 30, 2025 -0.20
Mar 31, 2025 -0.21
Dec 31, 2024 -0.29
Sep 30, 2024 -0.19
Jun 30, 2024 -0.22
Mar 31, 2024 -0.29
Dec 31, 2023 -0.28
Sep 30, 2023 -0.20
Jun 30, 2023 -0.23
Mar 31, 2023 -0.53
Dec 31, 2022 -0.38
Sep 30, 2022 0.54
API Access

Genelux EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=GNLX&period=max&api_key=YOUR_API_KEY